{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:25:51Z","timestamp":1770740751739,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,1,11]],"date-time":"2015-01-11T00:00:00Z","timestamp":1420934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s13277-015-3049-3","type":"journal-article","created":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T19:13:13Z","timestamp":1420917193000},"page":"4151-4156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study"],"prefix":"10.1007","volume":"36","author":[{"given":"Stella","family":"Capriglione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Plotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Montera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Angioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,11]]},"reference":[{"key":"3049_CR1","first-page":"125","volume":"35","author":"WT Creasman","year":"1989","unstructured":"Creasman WT. FIGO stage 1988 revision. GynecolOncol. 1989;35:125\u20137.","journal-title":"GynecolOncol"},{"key":"3049_CR2","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","volume":"60","author":"WT Creasman","year":"1987","unstructured":"Creasman WT, Morrow CP, Bundy BN, Homesly HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. Cancer. 1987;60:2035\u201341.","journal-title":"Cancer"},{"key":"3049_CR3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0090-8258(92)90307-5","volume":"45","author":"SC Rubin","year":"1992","unstructured":"Rubin SC, Hoskins WJ, Saigo PE, Nori D, Mychalczak B, Chapman D, et al. Management of endometrial adenocarcinoma with cervical involvement. Gynecol Oncol. 1992;45:294\u20138.","journal-title":"Gynecol Oncol"},{"key":"3049_CR4","unstructured":"Morrow CP, Curtin JP, Townsend DG. Tumors of the endometrium. In Synopsis of gynecologic oncology (5th edn), Morrow CP, Curtin JP (eds). Churchill Livingstone: New York, NY, 1998; 151\u2013185."},{"key":"3049_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiology.212.3.r99au29711","volume":"212","author":"K Kinkel","year":"1999","unstructured":"Kinkel K, Kaji Y, Yu KK, Segal MR, Powell CB, Hricak H. Radiologic staging in patients with endometrial cancer: a metaanalysis. Radiology. 1999;212:711\u20138.","journal-title":"Radiology"},{"key":"3049_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2003.11.018","volume":"93","author":"A Ayhan","year":"2004","unstructured":"Ayhan A, Taskiran C, Celik C, Yuce K. The long term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol Oncol. 2004;93:9\u201313.","journal-title":"Gynecol Oncol"},{"key":"3049_CR7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ygyno.2006.03.016","volume":"103","author":"H Nagar","year":"2006","unstructured":"Nagar H, Dobbs S, McClelland HR, Price J, McCluggage WG, Grey A. The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. Gynecol Oncol. 2006;103:431\u20134.","journal-title":"Gynecol Oncol"},{"key":"3049_CR8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.gco.0000175350.18308.73","volume":"17","author":"JF Magrina","year":"2005","unstructured":"Magrina JF. Outcomes of laparoscopic treatment for endometrial cancer. Curr Opin Obstet Gynecol. 2005;17:343\u20136.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"3049_CR9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00004728-199307000-00023","volume":"17","author":"MJ Varpula","year":"1993","unstructured":"Varpula MJ, Klemi PJ. Staging of uterine endometrial carcinoma with ultra-low field (0.02\u00a0T) MRI: a comparative study with CT. J Comput Assist Tomogr. 1993;17:641\u20137.","journal-title":"J Comput Assist Tomogr"},{"key":"3049_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1469-0705.1992.02010035.x","volume":"2","author":"B Karlsson","year":"1992","unstructured":"Karlsson B, Norstrom A, Granberg S, Wikland M. The use of endovaginal ultrasound to diagnose invasion of endometrial carcinoma. Ultrasound Obstet Gynecol. 1992;2:35\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3049_CR11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00004728-199509000-00013","volume":"19","author":"SH Kim","year":"1995","unstructured":"Kim SH, Kim HD, Song YS, Kang SB, Lee HP. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr. 1995;19:766\u201372.","journal-title":"J Comput Assist Tomogr"},{"key":"3049_CR12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/1097-0142(19820901)50:5<904::AID-CNCR2820500517>3.0.CO;2-V","volume":"50","author":"K Hasami","year":"1982","unstructured":"Hasami K, Matsuzawa M, Chen HF, Takahashi M, Sakura M. Computed tomography in the evaluation and treatment of endometrial carcinoma. Cancer. 1982;50:904\u20138.","journal-title":"Cancer"},{"key":"3049_CR13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2214\/ajr.166.3.8623626","volume":"166","author":"SA Teefey","year":"1996","unstructured":"Teefey SA, Stahl JA, Middleton WD, Huettner PC, Bernhard LM, Brown JJ, et al. Local staging of endometrial carcinoma: comparison of transvaginal and intraoperative sonography and gross visual inspection. AJR Am J Roentgenol. 1996;166:547\u201352.","journal-title":"AJR Am J Roentgenol"},{"key":"3049_CR14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/00004728-199611000-00003","volume":"20","author":"I Joja","year":"1996","unstructured":"Joja I, Asakawa M, Asakawa T, Nakagawa T, Kanazawa S, Kuroda M, et al. Endometrial carcinoma: dynamic MRI with turbo-flash technique. J Comput Assist Tomogr. 1996;20:878\u201387.","journal-title":"J Comput Assist Tomogr"},{"key":"3049_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1148\/radiology.185.1.1523309","volume":"185","author":"H Seki","year":"1992","unstructured":"Seki H, Kimura M, Sakai K. Myometrial invasion of endometrial carcinoma: assessment with plain and gadolinium enhanced MR imaging. Radiology. 1992;185:207\u201312.","journal-title":"Radiology"},{"key":"3049_CR16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7863\/jum.2000.19.9.639","volume":"19","author":"D Arko","year":"2000","unstructured":"Arko D, Takac I. High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer. J Ultrasound Med. 2000;19:639\u201343.","journal-title":"J Ultrasound Med"},{"key":"3049_CR17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1148\/radiol.2312021184","volume":"231","author":"R Manfredi","year":"2004","unstructured":"Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, et al. Local\u2013regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology. 2004;231:372\u20138.","journal-title":"Radiology"},{"key":"3049_CR18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/uog.2806","volume":"27","author":"F Smet De","year":"2006","unstructured":"De Smet F, De Brabanter J, Van den Bosch T, Pochet N, Amant F, Van Holsbeke C, et al. New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography. Ultrasound Obstet Gynecol. 2006;27:664\u2013971.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3049_CR19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2214\/ajr.176.3.1760603","volume":"176","author":"LA Hardesty","year":"2001","unstructured":"Hardesty LA, Sumkin JH, Hakim C, Johns C, Nath M. The ability of helical CT to preoperatively stage endometrial carcinoma. AJR Am J Roentgenol. 2001;176:603\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"3049_CR20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/uog.5295","volume":"31","author":"L Savelli","year":"2008","unstructured":"Savelli L, Ceccarini M, Ludovisi M, Fruscella E, de Laco PA, Salizzoni E, et al. Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet Gynecol. 2008;31:560\u20136.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"3049_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0090-8258(88)90032-7","volume":"30","author":"G Scambia","year":"1988","unstructured":"Scambia G, Benedetti Panici P, Baiocchi G, Perrone L, Greggi S, Mancuso S. CA 15\u20133 as a tumor marker in gynecological malignancies. Gynecol Oncol. 1988;30(2):265\u201373.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3049_CR22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","volume":"110","author":"RG Moore","year":"2008","unstructured":"Moore RG, Brown AK, Miller MC, Badgwell D, Lu Z, Allard WJ, et al. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecol Oncol. 2008;110(2):196\u2013201.","journal-title":"Gynecol Oncol"},{"key":"3049_CR23","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2011.109","volume":"104","author":"E Bignotti","year":"2011","unstructured":"Bignotti E, Ragnoli M, Zanotti L, Calza S, Falchetti M, Lonardi S, et al. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. Br J Cancer. 2011;104:1418\u201325.","journal-title":"Br J Cancer"},{"issue":"6","key":"3049_CR24","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"R Drapkin","year":"2005","unstructured":"Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005;65(6):2162\u20139.","journal-title":"Cancer Res"},{"issue":"12","key":"3049_CR25","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","volume":"5","author":"M Kobel","year":"2008","unstructured":"Kobel M, Kalloger SE, Boyd N, et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008;5(12):e232.","journal-title":"PLoS Med"},{"issue":"6","key":"3049_CR26","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s13277-012-0471-7","volume":"33","author":"F Plotti","year":"2012","unstructured":"Plotti F, Capriglione S, Terranova C, Montera R, Aloisi A, Damiani P, et al. Does HE4 have a role as biomarker in the recurrence of ovarian cancer? Tumour Biol. 2012;33(6):2117\u201323.","journal-title":"Tumour Biol"},{"issue":"2","key":"3049_CR27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s13277-013-1190-4","volume":"35","author":"R Angioli","year":"2014","unstructured":"Angioli R, Miranda A, Aloisi A, Montera R, Capriglione S, De Cicco NC, et al. A critical review on HE4 performance in endometrial cancer: where are we now? Tumour Biol. 2014;35(2):881\u20137.","journal-title":"Tumour Biol"},{"issue":"3","key":"3049_CR28","first-page":"321","volume":"54","author":"IM Duk","year":"1994","unstructured":"Duk IM. CA125: a useful marker in endometrial carcinoma. Am J Obstet Gynaecol Oncol. 1994;54(3):321\u20136.","journal-title":"Am J Obstet Gynaecol Oncol"},{"issue":"1","key":"3049_CR29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13277-012-0583-0","volume":"34","author":"R Angioli","year":"2013","unstructured":"Angioli R, Plotti F, Capriglione S, Montera R, Damiani P, Ricciardi R, et al. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study. Tumour Biol. 2013;34(1):571\u20136.","journal-title":"Tumour Biol"},{"issue":"20","key":"3049_CR30","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/1078-0432.CCR-13-1376","volume":"19","author":"R Angioli","year":"2013","unstructured":"Angioli R, Capriglione S, Aloisi A, Luvero D, Caf\u00e0 EV, Dugo N, et al. REM (risk of endometrial malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy. Clin Cancer Res. 2013;19(20):5733\u20139.","journal-title":"Clin Cancer Res"},{"issue":"9484","key":"3049_CR31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366(9484):491\u2013505.","journal-title":"Lancet"},{"issue":"2","key":"3049_CR32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2011.10.025","volume":"124","author":"E Kalogera","year":"2012","unstructured":"Kalogera E, Scholler N, Powless C, Weaver A, Drapkin R, Li J, et al. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. Gynecol Oncol. 2012;124(2):270\u20135.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3049_CR33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2012.04.022","volume":"126","author":"I Mutz-Dehbalaie","year":"2012","unstructured":"Mutz-Dehbalaie I, Egle D, Fessler S, Hubalek M, Fiegl H, Marth C, et al. HE4 is an independent prognostic marker in endometrial cancer patients. Gynecol Oncol. 2012;126(2):186\u201391.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"3049_CR34","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1515\/cclm-2011-0757","volume":"50","author":"L Zanotti","year":"2012","unstructured":"Zanotti L, Bignotti E, Calza S, Bandiera E, Ruggeri G, Galli C, et al. Human epididymis protein 4 as a serum for diagnosis of endometrial carcinoma and prediction of clinical out come. Clin Chem Lab Med. 2012;50(12):2189\u201398.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"3049_CR35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajog.2013.04.014","volume":"209","author":"SK Saarelainen","year":"2013","unstructured":"Saarelainen SK, Peltonen N, Lehtim\u00e4ki T, Perheentupa A, Vuento MH, M\u00e4enp\u00e4\u00e4 JU. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma. Am J Obstet Gynecol. 2013;209(2):142\u2013el-6.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"3049_CR36","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1007\/s13277-013-0814-z","volume":"34","author":"B Omer","year":"2013","unstructured":"Omer B, Genc S, Takmaz O, Dirican A, Kusku-Kiraz Z, Berkman S, et al. The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients. Tumor Biol. 2013;34(5):2645\u201350.","journal-title":"Tumor Biol"},{"issue":"7","key":"3049_CR37","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/IGC.0b013e3182229ad8","volume":"21","author":"RG Moore","year":"2011","unstructured":"Moore RG, Miller CM, Brown AK, Robison K, Steinhoff M, Lambert-Messerlian G. Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterus. Int J Gynecol Cancer. 2011;21(7):1185\u201390.","journal-title":"Int J Gynecol Cancer"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3049-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3049-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3049-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3049-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T17:41:40Z","timestamp":1747417300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3049-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3049"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3049-3","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,11]]}}}